Analyst firms · BofA Securities · PHVS
BofA Securities PHVS price target and rating history
Pharvaris N.V. (PHVS) · Health Care
BofA Securities rates Pharvaris N.V. (PHVS) Buy with a $44 price target, as of its latest action on Oct 23, 2026. It has published 3 rating actions on PHVS since August 2022, including 2 upgrades and 1 downgrade. Across 4 firms with a PHVS price target in the last 12 months, the median target is $48. BofA Securities's $44 is 8% below that.
- Current rating
- Buy
- Price target
- $44
- Median target, all firms
- $48
- Actions on PHVS
- 3
BofA Securities price target on PHVS
Every BofA Securities rating on PHVS
- Oct 23, 2026
- Oct 9, 2025
- Aug 22, 2022
How other firms rate PHVS
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BofA Securities | Buy | $44 | Oct 23, 2026 |
| Wells Fargo | Overweight | $55 | Jul 15, 2026 |
| Wolfe Research | Outperform | $42 | Apr 9, 2026 |
| RBC Capital Markets | Outperform | $52 | Mar 9, 2026 |
Questions about BofA Securities and PHVS
- What is BofA Securities's price target for PHVS?
- BofA Securities's latest stated price target for Pharvaris N.V. (PHVS) is $44, from its action on Oct 23, 2026.
- What is BofA Securities's rating on PHVS?
- BofA Securities rates PHVS Buy, a bullish rating, as of Oct 23, 2026.
- When did BofA Securities last change its view on PHVS?
- On Oct 23, 2026, BofA Securities upgrades to Buy from Neutral, price target $44.
- How does BofA Securities's PHVS target compare with other analysts?
- Across 4 firms with a PHVS price target in the last 12 months, the median target is $48. BofA Securities's $44 is 8% below that.
All BofA Securities ratingsPHVS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.